Suppr超能文献

B淋巴细胞突变率的测量。

Measurements of mutation rates in B lymphocytes.

作者信息

Wabl M, Jäck H M, Meyer J, Beck-Engeser G, von Borstel R C, Steinberg C M

出版信息

Immunol Rev. 1987 Apr;96:91-107. doi: 10.1111/j.1600-065x.1987.tb00511.x.

Abstract

It is established that somatic mutation is an important source of antibody diversity in vivo. It is also established that Igh-V gene segments are hypermutable in vitro. This is not a completely satisfactory situation. While there is no reason to believe that Igh-V genes are not hypermutable in vivo as well, direct experimental evidence is lacking. Perhaps experiments with transgenic mice will soon fill this gap. It is not so clear how much higher than normal the rate of hypermutation is. As far as we are aware, there are no direct measurements of mutation rates per base pair per cell generation in mammals, certainly not for lymphocyte cell lines. For a variety of reasons, it is difficult to measure very low mutation rates. The general consensus is that the normal rate should be somewhere between 10(-10) and 10(-12) mutations per base pair per cell generation. Therefore, an experiment designed to directly determine a rate using the compartmentalization test would involve hundreds of cultures, each containing at least 10(9) cells. It is not a trivial problem to find one or a few mutants among so many cells. It is simple to study mutation to resistance to a drug, for example, ouabain or azaguanine, but, as we discussed, there are technical and conceptual pitfalls. The vast excess of dead cells influences the growth of a few mutant cells, particularly in lymphocyte cell lines. Even if this problem could be solved, the mutation rate so obtained would be "per gene(s)" and not "per base pair". The problems associated with cytotoxic agents can be avoided by immunofluorescence methods in conjunction with selective cloning or cell sorting. Using these techniques, we have carried out extensive experiments to determine whether the immunoglobulin mutator system acts, at least partially, on genetic elements other than those in or near the heavy chain variable region gene segment. For an opal termination codon in a heavy chain constant region gene segment, the rate of reversion was less than 10(-7) per base pair per cell generation. This upper limit was fixed by the high rate of small deletions at the heavy chain locus. For an allotype mutation at B2m, the gene encoding beta 2 microglobulin, the rate of mutation was less than 10(-8). This upper limit could be lowered by at least two orders of magnitude by using a high-speed cell sorter.

摘要

已确定体细胞突变是体内抗体多样性的重要来源。也已确定免疫球蛋白重链可变区(Igh-V)基因片段在体外具有高度可突变性。但这并非完全令人满意的情况。虽然没有理由认为Igh-V基因在体内不具有高度可突变性,但缺乏直接的实验证据。或许转基因小鼠实验很快就能填补这一空白。目前尚不清楚高度突变率比正常水平高多少。据我们所知,尚无对哺乳动物每个细胞世代中每碱基对突变率的直接测量,淋巴细胞系肯定没有。由于各种原因,很难测量极低的突变率。普遍的共识是正常突变率应在每细胞世代每碱基对10^(-10)至10^(-12)次突变之间。因此,一个旨在使用分区试验直接确定突变率的实验将涉及数百个培养物,每个培养物至少包含10^9个细胞。在如此多的细胞中找到一个或几个突变体并非易事。研究对药物(例如哇巴因或氮杂鸟嘌呤)的抗性突变很简单,但正如我们所讨论的,存在技术和概念上的陷阱。大量死亡细胞会影响少数突变细胞的生长,在淋巴细胞系中尤其如此。即使这个问题能够解决,如此获得的突变率将是“每个基因”的,而不是“每碱基对”的。与细胞毒性剂相关的问题可以通过免疫荧光方法结合选择性克隆或细胞分选来避免。使用这些技术,我们进行了广泛的实验,以确定免疫球蛋白突变系统是否至少部分作用于重链可变区基因片段及其附近以外的遗传元件。对于重链恒定区基因片段中的一个乳白终止密码子,回复突变率低于每细胞世代每碱基对10^(-7)。这个上限是由重链基因座处的小缺失高发生率确定的。对于β2微球蛋白(B2m)编码基因的同种异型突变,突变率低于10^(-8)。通过使用高速细胞分选仪,这个上限可以至少降低两个数量级。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验